Trials
1 active
1 in total
What this is
- How it works
- A steroid that calms inflammation and the immune system.Corticosteroid FDA class
- How it’s given
- “Fluticasone propionate aqueous nasal spray (United States Pharmacopeia \[USP\]), 50 microgram (mcg)/metered spray.”In the company’s words, NCT07817134 on ClinicalTrials.gov
- Tested for
- Rhinitis Allergic, Rhinitis Seasonal
- Main trialPhase 4
- “This study is designed to visualize the response to use of fluticasone propionate nasal spray (Flonase Allergy Relief) to relieve facial allergy symptoms in individuals with moderate to severe seasonal allergic rhinitis (SAR).”In the company’s words, NCT07817134 on ClinicalTrials.gov
Other drugs for Rhinitis Allergic
- MM09Inmunotek S.L. · Phase 3
- LebrikizumabEli Lilly · Phase 3
- JYB1904Jemincare · Phase 2
- CM512Keymed Biosciences Co.Ltd · Phase 2
Coming up1
- DecPhase 4 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 4Not yet recruiting | Dec 2026 | A Study to Visualize Multi-Symptom Allergy in Adults With Seasonal Allergic Rhinitis |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026